Yüklüyor......
BH3 mimetic ABT-263 enhances the anticancer effects of apigenin in tumor cells with activating EGFR mutation
BACKGROUND: Mutated epidermal growth factor receptor (EGFR) is one of the most successful targets in cancer targeted therapy. While this treatment has benefited many patients with an activating EGFR mutation (EGFRm), almost all those who initially benefited will eventually develop acquired drug resi...
Kaydedildi:
| Yayımlandı: | Cell Biosci |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BioMed Central
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6651933/ https://ncbi.nlm.nih.gov/pubmed/31367332 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13578-019-0322-y |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|